AG490
AG490 has been studied in 6 papers since 2017: 1 observational study in people, 3 in animals, 2 in cells. It has not reached trials in people. The newest paper, Feb 25, 2025: “Occurrence of cellular senescence in chronic human shoulder tendinopathies and its attenuation ex vivo by inhibition of Enhancer of Zeste 2”.
At a glance
The findings reach people, from one lab or study; independent labs found the same change in cells. 6 independent labs in 2 countries.
“similarly to the senotherapeutic compound AG490”
None of its findings points the other way.
- 6 independent labs in 2 countries
- Funders: National Natural Science Foundation of China and others
- 1 of 11 findings with company ties
- Humans1
- Animals3
- Cells2
What did studies of AG490 find?
8Studies of AG490 measured 8 outcomes; the most studied is cellular senescence (4 studies).
Cellular senescence
downin human cells2downin cells1downin mice1
4 studies
Cellular senescence
downin human cells2downin cells1downin mice1
AG490 decreases cellular senescence in liver fibrotic factor-treated UC-MSCs.
“elevated senescence-associated secretory phenotype (SASP) and senescence in UC-MSCs and could be reversed by a specific JAK inhibitor AG490.”
Cellsin liver fibrotic factor-treated UC-MSCs
Cell death discovery
AG490 decreases cellular senescence in ischemic stroke mice.
“AG490 treatment reduced oxidative DNA damage and cellular senescence in the brains of mice following ischemic stroke.”
Animalsin ischemic stroke micebrain
Experimental neurology
AG490 decreases cellular senescence in cells (aged TSPCs; senescence and SASP).
“Pharmacological inhibition of JAK-STAT signaling pathway with AG490 similarly attenuated cellular senescence and senescence-associated secretory phenotype (SASP) of aged TSPCs”
Cellsaged TSPCs; senescence and SASPtendon
Frontiers in cell and developmental biology
AG490 decreases cellular senescence in BM-MSCs from SLE patients.
“AG490, the inhibitor of JAK2, and knockdown of STAT3 in BM-MSCs, could significantly reverse the senescence.”
Cellsin BM-MSCs from SLE patientsbone marrow
Acta biochimica et biophysica Sinica
Senescence-associated secretory phenotype (SASP)
downin humans1
1 study
Senescence-associated secretory phenotype (SASP)
downin humans1
AG490 decreases senescence-associated secretory phenotype (SASP) in humans (ex vivo tendon biopsies).
“similarly to the senotherapeutic compound AG490”
Human trialex vivo tendon biopsiestendon
Bone & joint research
Cartilage endplate degeneration
downin rats1
1 study
Cartilage endplate degeneration
downin rats1
AG490 decreases cartilage endplate degeneration in rats.
“the in vivo experiment results confirmed that the JAK2/STAT3 pathway inhibitor AG490 significantly reversed these effects.”
Animals
Journal of cellular and molecular medicine
cGAS–STING signaling
downin mice1
1 study
cGAS–STING signaling
downin mice1
AG490 inhibits cGAS–STING signaling in ischemic stroke mice.
“AG490 blocked cGAS/STING/NF-κBp65 expression.”
Animalsin ischemic stroke micebrain
Experimental neurology
Inflammation
downin mice1
1 study
Inflammation
downin mice1
AG490 decreases inflammation in ischemic stroke mice.
“reduced expression of pro-inflammatory cytokines, and decreased activation of pro-inflammatory microglia”
Animalsin ischemic stroke micebrain
Experimental neurology
Neurobehavioral defects
downin mice1
1 study
Neurobehavioral defects
downin mice1
AG490 decreases neurobehavioral defects in ischemic stroke mice.
“alleviated neurobehavioral defects”
Animalsin ischemic stroke mice
Experimental neurology
Brain infarct volume
downin mice1
1 study
Brain infarct volume
downin mice1
AG490 decreases brain infarct volume in ischemic stroke mice.
“alleviated neurobehavioral defects, reduced brain infarct volume”
Animalsin ischemic stroke micebrain
Experimental neurology
Self-renewal, migration, actin dynamics and stemness
upin cells1
1 study
Self-renewal, migration, actin dynamics and stemness
upin cells1
AG490 improves self-renewal, migration, actin dynamics and stemness in cells (aged TSPCs; via JAK-STAT pathway inhibition).
“inhibition of JAK-STAT signaling pathway also restored the age-related dysfunctions of TSPCs, including self-renewal, migration, actin dynamics, and stemness”
Cellsaged TSPCs; via JAK-STAT pathway inhibitiontendon
Frontiers in cell and developmental biology